Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000043921 | SCV000071934 | benign | Hereditary breast ovarian cancer syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000119249 | SCV000154100 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-04-10 | criteria provided, single submitter | literature only | |
Cancer Genetics and Genomics Laboratory, |
RCV000496608 | SCV000586932 | benign | not specified | 2017-04-18 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Molecular Medicine, |
RCV000496608 | SCV000588081 | uncertain significance | not specified | 2017-04-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000496608 | SCV000602806 | benign | not specified | 2016-11-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580530 | SCV000683457 | likely benign | Hereditary cancer-predisposing syndrome | 2015-03-11 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000119249 | SCV000743268 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000119249 | SCV001139015 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV003237717 | SCV002010728 | benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000580530 | SCV002533275 | benign | Hereditary cancer-predisposing syndrome | 2020-05-27 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000496608 | SCV002550296 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Breast Cancer Information Core |
RCV000119249 | SCV000145974 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 1999-04-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004542868 | SCV004798217 | likely benign | BRCA2-related disorder | 2021-03-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |